Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD

被引:152
作者
Gosker, HR
Lencer, NHMK
Franssen, FME
van der Vusse, GJ
Wouters, EFM
Schols, AMWJ
机构
[1] Univ Limburg, Dept Pulmonol, NL-6200 MD Maastricht, Netherlands
[2] Univ Limburg, Dept Cardiol, NL-6200 MD Maastricht, Netherlands
[3] Univ Limburg, Dept Physiol, NL-6200 MD Maastricht, Netherlands
关键词
chronic heart failure; COPD; daily activity level; exercise capacity; fat-free mass; isokinetic muscle function;
D O I
10.1378/chest.123.5.1416
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Aims: Chronic heart failure (CHF) and COPD are both characterized by muscular impairment. To assess whether the severity and functional consequences of muscular impairment are disease specific, we compared skeletal muscle function, body composition, and daily activity level relative to exercise capacity between these two disorders. Methods: Twenty-five patients with CHF and 25 patients with COPD, and 36 healthy gender- and age-matched control subjects underwent measurement of fat-free mass (FFM) [by bioelectrical impedance analysis] as an index of muscle mass. Quadriceps and biceps functions were tested by isokinetic methods, and daily activity level was assessed by the Physical Activity Scale for Elderly (PASE) questionnaire. Peak oxygen consumption (Vo(2)peak) was measured by incremental cycle ergometry. Results: PASE results were similar in patients with CHF and in patients with COPD, each group scoring lower than control subjects. FFM was also lower in patients than control subjects and correlated closely with quadriceps and biceps strength in all three subgroups, R values ranging from 0.63 to 0.78, with identical slopes. FFM also correlated significantly with Vo(2)peak (p < 0.05), but slopes were less steep in patients than in control subjects. The type and severity of muscle dysfunction were similar in each group of patients. There were no significant correlations between indexes of cardiopulmonary function and muscle function or exercise performance in patients with CHF or in patients with COPD. In both control subjects and patients, FFM was the most significant determinant of Vo(2)peak. Conclusion: Muscle dysfunction is not limited to the lower limbs, but generalized and comparable between patients with CHF and patients with COPD with similar exercise capacity. FFM is a strong predictor of peripheral muscle strength, to a lesser extent of Vo2peak, and not at all of peripheral muscle endurance.
引用
收藏
页码:1416 / 1424
页数:9
相关论文
共 31 条
[1]   STATISTICAL GUIDELINES FOR CONTRIBUTORS TO MEDICAL JOURNALS [J].
ALTMAN, DG ;
GORE, SM ;
GARDNER, MJ ;
POCOCK, SJ .
BRITISH MEDICAL JOURNAL, 1983, 286 (6376) :1489-1493
[2]  
Anker SD, 1997, EUR HEART J, V18, P259
[3]  
[Anonymous], 1987, AM REV RESPIR DIS, V136, P225
[4]   Peripheral muscle weakness in patients with chronic obstructive pulmonary-disease [J].
Bernard, S ;
LeBlanc, P ;
Whittom, F ;
Carrier, G ;
Jobin, J ;
Belleau, R ;
Maltais, F .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (02) :629-634
[5]  
BULLER NP, 1991, BRIT HEART J, V65, P20
[6]   PREDICTING MAXIMAL EXERCISE VENTILATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
CARTER, R ;
PEAVLER, M ;
ZINKGRAF, S ;
WILLIAMS, J ;
FIELDS, S .
CHEST, 1987, 92 (02) :253-259
[7]   Interpretation of high wedge pressure on exercise in patients with chronic obstructive pulmonary disease [J].
Chabot, F ;
Schrijen, F ;
Poincelot, F ;
Polu, JM .
CARDIOLOGY, 2001, 95 (03) :139-145
[8]   LUNG-FUNCTION IMPAIRMENT AS A GUIDE TO EXERCISE LIMITATION IN WORK-RELATED LUNG DISORDERS [J].
COTES, JE ;
ZEJDA, J ;
KING, B .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (05) :1089-1093
[9]  
DVIR Z, 1995, ISOKINETICS MUSCLE T, P199
[10]   Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease [J].
Engelen, MPKJ ;
Schols, AMWJ ;
Does, JD ;
Wouters, EFM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2000, 71 (03) :733-738